TP53 and lung carcinoma: In the three TCGA lung cancer datasets (LUAD, LUSC, SCLC), TP53 was the most frequently (32%) mutated gene, with differences among the three cohorts: 46% in LUAD, 81% in LUSC, and 86% in SCLC.